Skip to main content

Table 1 Demographic information

From: Pharmacokinetics and pharmacodynamics of fenoldopam mesylate for blood pressure control in pediatric patients

  

Fenoldopam (mcg/kg/min)

 

Demographic

Placebo

0.05

0.2

0.8

3.2

P-valuea

Characteristic

(N = 16)

(N = 16)

(N = 15)

(N = 15)

(N = 15)

 

Gender

     

0.802

   Female

6 (38%)

7 (47%)

8 (50%)

5 (33%)

8 (53%)

 

   Male

10 (63%)

8 (53%)

8 (50%)

10 (67%)

7 (47%)

 

Age (months)

     

0.917

   Mean (SD)

45.6 (48.82)

60.6 (48.82)

55.9 (50.15)

49.3 (54.92)

48.2 (45.97)

 

Height (cm)

(N = 15)

(N = 13)

(N = 14)

(N = 14)

(N = 15)

0.884

   Mean (SD)

84.7 (27.59)

95.1 (32.65)

91.4 (32.17)

94.8 (34.32)

89.8 (22.24)

 

Weight (kg)

     

0.687

   Mean (SD)

14.7 (9.04)

18.3 (13.55)

19.1 (14.57)

16.2 (10.95)

14.1 (7.07)

 
  1. SD = standard deviation
  2. a P-values are from a Fisher's exact test (gender and age category) or a one-way analysis of variance (age, height, weight).